Thymoglobulin for induction or rejection therapy in pancreas allograft recipients: A single centre experience

Clinical Transplantation

Volumn 16, Issue SUPPL. 7, 2002, Pages 34-44

  Trofe, Jennifer ^a   Stratta, Robert J ^a,b   Egidi, M Francesca ^a   Lo, Agnes ^a   Gaber, Lillian W ^a   Shokouh Amiri, M Hosein ^a   Grewal, Hani P ^a   Honaker, Marsha ^a   Hardinger, Karen ^a   Alloway, Rita R ^a   Gaber, A Osama ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

Antibody induction; Immunosuppression; Pancreas transplantation; Rejection; Simultaneous kidney pancreas transplant; Solitary pancreas transplant; Thymoglobulin

Indexed keywords

THYMOCYTE ANTIBODY; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; TACROLIMUS;

BACTERIAL INFECTION; CANDIDA ALBICANS; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DRUG EFFICACY; DRUG SAFETY; FEVER; GRAFT REJECTION; HUMAN; INFECTION COMPLICATION; KIDNEY BIOPSY; LEUKOPENIA; MYCOSIS; PANCREAS TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; REVIEW; THROMBOCYTOPENIA; TOXOPLASMOSIS; VIRUS INFECTION; ADULT; ARTICLE; FEMALE; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

ADULT; ANTILYMPHOCYTE SERUM; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MUROMONAB-CD3; MYCOPHENOLIC ACID; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; TACROLIMUS;

EID: 19044391448     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.16.s7.5.x     Document Type: Review

References (22)

1. GRUESSNER AC, SUTHERLAND DER. Analysis of United States (US) and non-US pancreas transplant as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). In: CECKA JM, TERASAKI PI, eds. Clinical Transplants 1998. Los Angeles: UCLA Tissue Typing Laboratory, 1999: 53.
2. SOLLINGER HW, ODORICO JS, KNECHTLE SJ, D'ALESSANDRO AM, KALAYOGLU M, PIRSCH JD. Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg 1998: 288: 284.
3. CANTAROVICH D, KARAM G, GIRAL-CLASSE M et al. Randomized comparison of triple therapy and anti-thymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation. Kidney Int 1998: 54: 1351.
4. LE FRANCOIS N, RAAELE P, MARTINENGHI S et al. Prophylactic polyclonal versus monoclonal antibodies in kidney and pancreas transplantation. Transplant Proc 1990: 22: 632.
5. STRATTA RJ. Immunosuppression in pancreas transplantation: progress, problems, and perspective. Transplant Immunol 1998: 6: 69.
6. STRATTA RJ, ALLOWAY RR. Pancreas transplantation for diabetes mellitus. Bio Drugs 1998: 10: 347.
7. PAPADIMITRIOU JC, DRACHENBERG CB, WILAND A et al. Histologie grading of acute allograft rejection in pancreas needle biopsy: correlation to serum enzymes, glycemia, and response to immunosuppressive treatment. Transplantation 1998: 66: 1741.
8. SUTHERLAND DER, MOUDRY-MUNNS K, GRUESSNER A. Pancreas transplant results in United Network for Organ Sharing (UNOS) United States of America (USA) Registry with a comparison to non-USA data in the international registry. In: TERASAKI PI, CECKA JM, eds. Clinical Transplants 1993. Los Angeles: UCLA Tissue Typing Laboratory, 1994: 47.
9. TROFE J, ALLOWAY RR, GODKIN J, KANO J, STRATTA RJ, GABER AO. Thymoglobulin for the prophylaxis or treatment of rejection in pancreas allograft recipients: results of the US compassionate use experience. Transplantation 1999: 67: abstract S209.
10. STRATTA RJ, GABER AO, SHOKOUH-AMIRI MH, REDDY KS, EGIDI MF, GREWAL HP. A prospective comparison of systemic-bladder versus portal-enteric drainage in vascularized pancreas transplantation. Surgery 2000: 127: 217.
11. STRATTA RJ. Ganciclovir/acyclovir and fluconazole prophylaxis after simultaneous kidney pancreas transplantation. Transplant Proc 1998: 30: 262.
12. SOMERVILLE T, HURST G, ALLOWAY RR et al. Superior efficacy of oral ganciclovir over oral acyclovir for CMV prophylaxis in kidney/pancreas and pancreas alone recipients. Transplant Proc 1998: 30: 1546.
13. GABER LW, STRATTA RJ, LO A et al. Importance of surveillance biopsy monitoring in solitary pancreas transplant patients receiving tacrolimus and mycophenolate mofetil. Transplantation 2000: 69: abstract S269.
14. NYMANN T, HATHAWAY DK, SHOKOUH-AMIRI MD et al. Patterns of acute rejection in portal-enteric versus systemic-bladder pancreas-kidney transplantation. Clin Transplant 1998: 12: 175.
15. SOLEZ K, AXELSEN RA, BENEDIKISSON H et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993: 44: 411.
16. DRACHENBERG CB, PAPADIMITRIOU JC, KLASSEN DK et al. Evaluation of pancreas transplant needle biopsy: reproducibility and revision of histologic grading system. Transplantation 1997: 63: 1579.
17. BONNEFOY-BERNARD N, FLACHER M, REVILLARD JP. Anti-proliferative effects of antilymphocyte globulins on B-cells and B-cell lines. Blood 1992: 79: 2164.
18. GABER AO, FIRST MR, TESI RJ et al. Results of the double-blind, randomized, multicenter phase III clinical trial of Thymoglobulin versus Atgam on the treatment of acute rejection episodes after renal transplantation. Transplantation 1998: 66: 29.
19. WILAND A, FINK JC, PHILOSOPHE B, FARNEY A, SCHWEITZER EJ, COLONNA JD, WEIR MR, BARTLETT ST. Peripheral administration of thymoglobulin for induction therapy in pancreas transplantation. Transplant Proc 2001: 33: 1910.
20. WILAND A, FINK JC, FARNEY A, SCHWEITZER EJ, WEIR MR, BARTLETT ST. Cost effective measures to administer Thymoglobulin for induction therapy. Presented at the 18th International Congress of the Transplantation Society, Rome, Italy. August 27-September 1, 2000.
21. PEDDI VR, BRYANT M, ROY-CHAUDRY P, WOODLE ES, FIRST MR. Thymoglobulin induction therapy in cadaveric renal allograft recipients: intermittent dosing with CD3+ lymphocyte count monitoring. Transplantation 2000: 69: abstract S160.
22. GUTTMAN RD, FLEMING C. Sequential biologic immunosuppression: induction therapy with rabbit antithymocyte globulin. Clin Transplant 1997: 11: 185.